BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6103939)

  • 1. In vitro and in vivo alpha-blocking activity of thymoxamine and its two metabolites.
    Creuzet MH; Prat G; Malek A; Fauran F; Roquebert J
    J Pharm Pharmacol; 1980 Mar; 32(3):209-13. PubMed ID: 6103939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinoradrenergic activity of thymoxamine and its metabolites in rats.
    Roquebert J; Demichel P; Malek A
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):12-25. PubMed ID: 6111983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the pre and post-synaptic alpha blocking activity of thymoxamine and its metabolites in the rat vas deferens (author's transl)].
    Roquebert J; Demichel P; Malek A; Canellas J
    J Pharmacol; 1981; 12(1):15-25. PubMed ID: 6111626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thymoxamine and its metabolites on clonidine-induced hypotension and bradycardia in rats.
    Roquebert J; Demichel P; Malek A
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):116-27. PubMed ID: 6215903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Is thymoxamine a specific alpha-adrenoceptor blocking agent?
    Fawke L
    Br J Pharmacol; 1972 Feb; 44(2):362P-362P. PubMed ID: 4148921
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-specific, time-dependent desensitization of the vas deferens and anococcygeus preparations of the rat to alpha 1-adrenoceptor antagonists and atropine.
    Onnen I
    Br J Pharmacol; 1984 Sep; 83(1):7-14. PubMed ID: 6148980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of uptake1 on alpha-adrenoceptor antagonist potency in dog saphenous vein.
    Humphrey PP
    Br J Pharmacol; 1978 Aug; 63(4):665-9. PubMed ID: 28806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1- and alpha 2-adrenoceptor selectivity of moxisylyte (thymoxamine) and its metabolites in the pithed rat.
    Roquebert J; Malek A; Creuzet MH; Cognie F; Pontagnier H
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):282-93. PubMed ID: 6320755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations.
    Collis MG; Alps BJ
    J Pharm Pharmacol; 1973 Aug; 25(8):621-8. PubMed ID: 4148430
    [No Abstract]   [Full Text] [Related]  

  • 12. Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence.
    de Tejada IS; Garvey DS; Schroeder JD; Shelekhin T; Letts LG; Fernández A; Cuevas B; Gabancho S; Martínez V; Angulo J; Trocha M; Marek P; Cuevas P; Tam SW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):121-8. PubMed ID: 10381767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of thymoxamine. I. Studies with 14C-thymoxamine in rats.
    Vollmer KO; Liedtke B; Poisson A; von Hodenberg A; Steinbrecher W
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):61-9. PubMed ID: 3161738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thymoxamine on ouabain-induced arrhythmias in dogs.
    Oguro K; Hashimoto H; Nakashima M
    Tohoku J Exp Med; 1982 Aug; 137(4):361-8. PubMed ID: 6214872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of thymoxamine. III. Structure elucidation of the metabolites and interspecies comparison.
    Vollmer KO; von Hodenberg A
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):139-45. PubMed ID: 2931278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of thymoxamine on guinea-pig ileum contractions.
    Lograno MD; Daniele E; Conte-Camerino D
    Pharmacol Res Commun; 1984 Nov; 16(11):1101-10. PubMed ID: 6097922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
    Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
    Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
    Harsing LG; Vizi ES
    J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of thymoxamine: identification of metabolites in rat.
    Feniou C; Neau B; Prat G; Cheze C; Fauran F; Roquebert J
    J Pharm Pharmacol; 1980 Feb; 32(2):104-7. PubMed ID: 6103028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.